TRCT
RPID icon

Tower Research Capital (TRC)’s Rapid Micro Biosystems RPID Stock Holding History

Tower Research Capital (TRC)’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-317
Closed -$919 – 5498
2025
Q4 		$919 Buy
+317
New +$1.1K ﹤0.01% 4795
2025
Q2 		– Sell
-350
Closed -$924 – 5528
2025
Q1 		$924 Sell
350
-8,770
-96% -$20K ﹤0.01% 4800
2024
Q4 		$8.21K Buy
9,120
+4,513
+98% +$4.54K ﹤0.01% 4011
2024
Q3 		$4.1K Sell
4,607
-3,689
-44% -$2.87K ﹤0.01% 4672
2024
Q2 		$5.47K Buy
8,296
+2,749
+50% +$2.35K ﹤0.01% 4675
2024
Q1 		$5.38K Sell
5,547
-4,260
-43% -$4.14K ﹤0.01% 4550
2023
Q4 		$7.26K Buy
9,807
+6,655
+211% +$6.81K ﹤0.01% 4639
2023
Q3 		$3.4K Sell
3,152
-710
-18% -$706 ﹤0.01% 5009
2023
Q2 		$3.86K Sell
3,862
-708
-15% -$716 ﹤0.01% 5017
2023
Q1 		$6K Sell
4,570
-5,831
-56% -$7.57K ﹤0.01% 4866
2022
Q4 		$12K Sell
10,401
-6,962
-40% -$16.9K ﹤0.01% 3737
2022
Q3 		$56K Buy
17,363
+7,645
+79% +$29.7K ﹤0.01% 3068
2022
Q2 		$42K Buy
9,718
+8,199
+540% +$38.2K ﹤0.01% 3063
2022
Q1 		$10K Buy
1,519
+520
+52% +$3.83K ﹤0.01% 4338
2021
Q4 		$11K Buy
999
+210
+27% +$3.28K ﹤0.01% 4446
2021
Q3 		$15K Buy
+789
New +$16.3K ﹤0.01% 3993

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
EFA
Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s RPID Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Rapid Micro Biosystems (RPID) in Q1 2026, closing a stake of 317 shares — an estimated $919 sold.

Tower Research Capital (TRC) first reported a position in RPID in Q3 2021 and held it in 16 quarters. The position peaked at $56K in Q3 2022. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Rapid Micro Biosystems position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 317 Rapid Micro Biosystems shares in Q1 2026, an estimated $919.
  • Tower Research Capital (TRC) first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 16 quarters.
  • Tower Research Capital (TRC)'s Rapid Micro Biosystems position peaked at $56K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.